Welcome to our dedicated page for Wns Hldgs SEC filings (Ticker: WNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
When you look for deep insights into WNS (Holdings) Ltd —a BPM leader serving airlines, insurers, and banks —you re met with a maze of cross-border disclosures. Annual Form20-F footnotes, frequent 6-K updates, and dense tables make it hard to isolate segment margins or cash-flow impacts from new outsourcing contracts. That s why investors searching WNS insider trading Form 4 transactions or WNS quarterly earnings report 10-Q filing land here first. We centralize every line item, turning WNS SEC filings explained simply into a reality.
Stock Titan s platform adds clarity. Our AI reads each submission the moment it hits EDGAR and produces plain-English takeaways you can act on. Expect real-time alerts for WNS Form 4 insider transactions real-time and concise tables that map revenue by vertical. Need quick WNS earnings report filing analysis or help understanding WNS SEC documents with AI? Just open the AI summary, or dive deeper with:
- Interactive charts inside WNS executive stock transactions Form 4
- Side-by-side views of WNS annual report 10-K simplified versus prior years
- Tag-based search across WNS proxy statement executive compensation data
- Event timelines with WNS 8-K material events explained in minutes
These tools matter because WNS s revenue rests on multiyear outsourcing contracts; a single customer renewal or pricing clause disclosed in a 6-K can shift future cash flows. Our AI surfaces those contract details, tracks headcount trends that foreshadow margin changes, and flags unusual insider activity long before the next call. Whether you compare travel-segment growth, monitor attrition expenses, or watch for governance updates, you ll save hours and make decisions with confidence.
WNS (Holdings) Limited (NYSE: WNS) has furnished an 8-K to disclose the next procedural step in its pending acquisition by Capgemini S.E. The company has released the Scheme Document and related proxy materials, starting the formal shareholder approval process required under Jersey law. Two shareholder votes—a Court-sanctioned meeting and a General Meeting—are scheduled for 29 Aug 2025. Approval of the Scheme and the related amendment of WNS’s Articles of Association are key conditions to closing.
The filing supplies a press release (Ex. 99.1), the full Scheme Document (Ex. 99.2) and associated notices and proxy cards (Exs. 99.3-99.6). The information is furnished under Item 7.01 and is therefore not deemed "filed" for liability purposes. Forward-looking statements outline typical deal risks, including potential failure to receive shareholder or regulatory approvals, possible termination of the agreement, business disruption, and transaction costs. No financial terms were updated in this filing, but today’s release confirms the transaction timeline and keeps the deal on track toward an expected closing once all conditions are satisfied.
KB Financial Group Inc. filed a Form 6-K stating that its board approved a quarterly cash dividend of KRW 920 per common share. Based on 364,151,975 shares outstanding, the tentative aggregate payout is KRW 335,019,817,000.
The record date is 11 August 2025 (Korea time). In line with Korean capital-markets regulations, the dividend will be paid within one month after the 24 July 2025 board resolution. The final amount may change if share count is reduced by ongoing treasury-share purchases referenced in a separate 6-K filed on the same date.
No earnings data or additional operational details were disclosed; the document is limited to this capital-return announcement.
WNS (Holdings) Limited has signed a Transaction Agreement with Capgemini S.E. under which Capgemini will acquire all outstanding WNS ordinary shares via a Jersey court-sanctioned scheme of arrangement for $76.50 in cash per share. The deal covers all equity, including the cash settlement of vested RSUs and a contractual cash-settlement mechanism for 80% of unvested RSUs, which will continue to vest on their original schedules.
Key conditions include (i) antitrust and regulatory clearances in the U.S., U.K. and other jurisdictions, (ii) approval of the scheme by a majority in number representing at least 75% of votes cast by WNS shareholders, and (iii) sanction by the Royal Court of Jersey. No financing contingency applies. Closing is targeted by year-end 2025, with an outside date of 7 April 2026 (extendable to 7 August 2026).
The agreement contains customary representations, covenants and “no-shop� restrictions, with fiduciary-out provisions for superior proposals. Termination fees are significant: $118 million payable by WNS in specified circumstances (including board change-of-recommendation) and $169 million payable by Capgemini for intentional, material breaches of its regulatory-filing obligations. The transaction is not subject to financing; Capgemini commits to divestitures or other remedies required by regulators.
Following completion, WNS shares will be delisted from NYSE and deregistered under the Exchange Act. Directors owning ~1.9% of the shares have entered into voting agreements supporting the scheme.